SCHEMBL11980432

SCHEMBL11980432

Cc1ccccc1Sc1nc2c(N)ncnc2[nH]1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 2/20 0.42
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
ERBB2 P04626 1/20 0.39
HSP90AA1 P07900 1/20 0.39
HSP90AB1 P08238 1/20 0.39
PI4KA P42356 5/20 0.38
PI4K2B Q8TCG2 5/20 0.38
PI4K2A Q9BTU6 5/20 0.38
PI4KB Q9UBF8 5/20 0.38
LMNA P02545 2/20 0.37
TSHR P16473 1/20 0.37
PIK3CD O00329 1/20 0.37
PIK3CA P42336 1/20 0.37
PIK3CB P42338 1/20 0.37
PIK3CG P48736 1/20 0.37
PRKDC P78527 1/20 0.37
MEN1 O00255 1/20 0.37
MAPT P10636 1/20 0.37
STAT3 P40763 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16487461 0.84 HSP90B1 (0.47) MAP4K4ERBB2HSP90AA1HSP90AB1LMNA
SCHEMBL16486560 0.82 TYMS (0.46) ERBB2HSP90AA1HSP90AB1PI4KAPI4K2B
SCHEMBL28068959 0.82 HSP90AA1 (0.38) MAP4K4KDM4EERBB2HSP90AA1HSP90AB1
SCHEMBL13050401 0.82 HSP90AA1 (0.42) MAP4K4KDM4EERBB2HSP90AA1HSP90AB1
SCHEMBL5132695 0.81 LMNA (0.48) MAP4K4ALDH1A1PI4KAPI4K2BPI4K2A
SCHEMBL14467034 0.80 ERBB2 (0.41) MAP4K4ERBB2HSP90AA1HSP90AB1
SCHEMBL1669646 0.80 ERBB2 (0.40) MAP4K4KDM4EALDH1A1ERBB2HSP90AA1
SCHEMBL12454385 0.80 ALDH1A1 (0.42) KDM4EALDH1A1MEN1MAPTSTAT3
SCHEMBL16486451 0.79 HSP90B1 (0.44) MAP4K4KDM4EERBB2HSP90AA1HSP90AB1
SCHEMBL16487160 0.78 HSP90AA1 (0.45) MAP4K4ERBB2HSP90AA1HSP90AB1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9926321-B2 Hsp90 inhibitors SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2018-03-27 US disclosed
US-20160310497-A1 PURINE DERIVATIVES USEFUL AS HSP90 INHIBITORS SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH 2016-10-27 US disclosed
US-20160264577-A1 HSP90 INHIBITORS SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH 2016-09-15 US disclosed
US-9346808-B2 Hsp90 inhibitors SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2016-05-24 US disclosed
US-9328114-B2 Hsp90 inhibitors SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2016-05-03 US disclosed
US-20120208806-A1 Hsp90 Inhibitors SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2012-08-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160264577-A1 HSP90 INHIBITORS HSP90AB1, HSP90B1, HSP90AB2P MAP4K4 991/4885KDM4E 3174/4885ALDH1A1 4061/4885
US-20120208806-A1 Hsp90 Inhibitors HSP90B1, HSP90AB1, HSP90AB2P MAP4K4 1838/4885KDM4E 4277/4885ALDH1A1 2794/4885
US-20160310497-A1 PURINE DERIVATIVES USEFUL AS HSP90 INHIBITORS XDH, HSP90B1, HSP90AA1 MAP4K4 2289/4885KDM4E 3517/4885ALDH1A1 1795/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.